NCT03463278 is a clinical trial of Pregnancy Rate in Pregnancy, Ovarian, sponsored by Assisting Nature.

Who is sponsoring NCT03463278?

NCT03463278 is sponsored by Assisting Nature.

What drugs are being tested in NCT03463278?

Interventions in NCT03463278: Pregnancy Rate.

What condition does NCT03463278 study?

NCT03463278 studies Pregnancy, Ovarian.

Is NCT03463278 still recruiting?

NCT03463278 is currently status unknown. Last updated 8 October 2020.

Last reviewed 2020-10-08 · How we verify

NCT03463278

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

The Number of Blastocysts Formed in the Outcome of Freeze All Strategy: COMFFETI Trial, Cumulative Delivery Rate

Status unknown Last updated 8 October 2020

What this trial tests

trial testing Pregnancy Rate in Pregnancy, Ovarian in 160 participants. Status unknown.

Timeline

1 November 2013

Primary endpoint
31 December 2021

31 December 2021

Quick facts

Lead sponsor	Assisting Nature
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	160
Start date	1 November 2013
Primary completion	31 December 2021
Estimated completion	31 December 2021
Sites	1 location across Greece

Drugs / interventions tested

Pregnancy Rate

Conditions studied

Pregnancy, Ovarian — all drugs for Pregnancy, Ovarian →

Sponsor

Assisting Nature

Who can join

Adults 20 to 39, female only, with Pregnancy, Ovarian. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

A prospective study of the blastulation rate in the outcome of the Freeze all strategy

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

In Freeze-All Strategy, Cumulative Live Birth Rate (CLBR) Is Increasing According to the Number of Blastocysts Formed in Women <40 Undergoing Intracytoplasmic Sperm Injection (ICSI).
Papanikolaou E, Chartomatsidou T, Timotheou E, Tatsi P, et al · · 2019 · cited 7× · PMID 31333581 · DOI 10.3389/fendo.2019.00427

Verify or expand the search:

Other trials of Pregnancy Rate

Trials testing the same drug.

NCT03684421 — Clinical and Live Birth Rates After Following Long Antagonist Protocol Versus Classical Antagonist Protocol · unknown

Other Assisting Nature trials

Trials by the same sponsor.

NCT03240159 — Long Antagonist Protocol for IVF With Single Luteal Dose of Degarelix · Phase 3 · unknown
NCT03684421 — Clinical and Live Birth Rates After Following Long Antagonist Protocol Versus Classical Antagonist Protocol · unknown
NCT03693534 — Clinical and Live Birth Rates After Following Long Antagonist Protocol Versus Long Agonist Protocol · unknown

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03463278 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Assisting Nature
Last refreshed: 8 October 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03463278.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing